Compounds > oxcarbazepine
Page last updated: 2024-08-23

oxcarbazepine and risperidone

oxcarbazepine has been researched along with risperidone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Azzoni, A; Raja, M1
Cacciola, M; D'Arrigo, C; La Torre, D; Migliardi, G; Pacetti, M; Rosaria Muscatello, M; Spina, E; Zoccali, R1
Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM1
Davis, MC; Kruse, JL1
Adams, CE; Ahmed, U; Hussein, M; Miramontes, K; Ostinelli, EG; Rehman, FU1
Benabderrahmane, M; Bourafai-Aziez, A; Carlier, L; Coadou, G; Jouanne, M; Oulyadi, H; Paysant, H; Poulain, L; Ravault, D; Sebban, M; Sopková-de Oliveira Santos, J; Voisin-Chiret, AS; Weiswald, LB1

Reviews

2 review(s) available for oxcarbazepine and risperidone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    The Cochrane database of systematic reviews, 2018, 04-10, Volume: 4

    Topics: Administration, Oral; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Oxcarbazepine; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tranquilizing Agents; Valproic Acid

2018

Other Studies

8 other study(ies) available for oxcarbazepine and risperidone

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Oxcarbazepine, risperidone and atenolol overdose with benign outcome.
    The international journal of neuropsychopharmacology, 2003, Volume: 6, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Alcoholism; Anticonvulsants; Antipsychotic Agents; Atenolol; Bipolar Disorder; Carbamazepine; Cocaine-Related Disorders; Drug Overdose; Humans; Male; Oxcarbazepine; Risperidone

2003
Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
    Epilepsia, 2005, Volume: 46, Issue:5

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Olanzapine; Oxcarbazepine; Risperidone

2005
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
    Journal of affective disorders, 2010, Volume: 121, Issue:1-2

    Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid

2010
New-onset extrapyramidal symptoms following oxcarbazepine discontinuation in a child receiving risperidone.
    Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:3

    Topics: Antipsychotic Agents; Carbamazepine; Child; Drug Interactions; Drug Therapy, Combination; Humans; Male; Movement Disorders; Oxcarbazepine; Risperidone; Substance Withdrawal Syndrome

2014
Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Apoptosis Regulatory Proteins; Deferasirox; Drug Repositioning; Lenalidomide; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Oxcarbazepine; Risperidone; Torsemide

2021